Read further: NOACs vs. VKAs: Differential Effects on Dementia Risk in Atrial Fibrillation Patients
You may also like
Combining Monoclonal Antibodies to Prevent Viral...
New Multidimensional Framework for Characterizing...
Obicetrapib-Ezetimibe Combination Reduces LDL...
Amiloride Noninferior to Spironolactone for Reducing...
Flavan-3-Ols: A Potential Dietary Intervention for...
One in Seven U.S. Adults Aged 30-59 Have High 30-Year...
About the author
